⌘K

Login Start Free

Home/Filings/4/0001694665-21-000084

4//SEC Filing

Darzi Lord Ara 4

Accession 0001694665-21-000084

CIK 0001694665other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:02 PM ET

Size

7.4 KB

Accession

0001694665-21-000084

Insider Transaction Report

Form 4

Period: 2021-06-08

Evelo Biosciences, Inc.EVLO

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-09+1,810→ 1,810 total
Exercise: $14.19Exp: 2031-06-08→ Common Stock (1,810 underlying)
Award
Stock Option (Right to Buy)
2021-06-08+15,690→ 15,690 total
Exercise: $14.60Exp: 2031-06-07→ Common Stock (15,690 underlying)

Footnotes (1)

[F1]The option vests on the earlier of June 8, 2022 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.

Documents

1 file

4
wf-form4_162344175098404.xmlPrimary
FORM 4

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

Entity typeother

Related Parties

1

filerCIK 0001738865

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 4:02 PM ET
Size: 7.4 KB

View on SEC.gov